Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > Á¤º¸Åë½Å > ¼ÒÇÁÆ®¿þ¾î > Strategic Analysis of Global Scientific Business Intelligence (Sci-BI) in Pharmaceutical and Biotechnology Markets
Ä«Å×°í¸®
Á¤º¸Åë½Å (10884)
±¤³×Æ®¿öÅ© (223)
±â¾÷Á¤º¸ ÇÁ·ÎÇÊ (558)
³×Æ®¿öÅ© (657)
³×Æ®¿öÅ©/Á¢¼Ó±â±â (256)
µ¥ÀÌÅͼ¾ÅÍ (332)
µðÁöÅйæ¼Û (294)
¸ð¹ÙÀÏ °¡ÀÔÀÚ (114)
¸ð¹ÙÀϱâ±â (768)
¹«¼±·£/¿ÍÀ̸ƽº (559)
ºê·Îµå¹êµå (338)
¼ÂÅé¹Ú½º (65)
¼ÒÇÁÆ®¿þ¾î (977)
¿Â¶óÀθ¶ÄÉÆÃ (142)
À¥¼­ºñ½º (539)
À§¼ºÅë½Å (143)
ÀüÀÚ»ó°Å·¡ (207)
Â÷¼¼´ë ¹«¼±Åë½Å (499)
ÄÁ¹öÀü½º (171)
ÄÁÅÙÃ÷ (610)
Äݼ¾ÅÍ (106)
ÅëÇÕÄ¿¹Â´ÏÄÉÀÌ¼Ç (298)
IT ¾Æ¿ô¼Ò½Ì (288)
ITº¸¾È (489)
LBS (160)
NFC (151)
RFID (216)
½ÃÀ庸°í¼­

Strategic Analysis of Global Scientific Business Intelligence (Sci-BI) in Pharmaceutical and Biotechnology Markets

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2008³â 12¿ù »óǰÄÚµå 79479
ÆäÀÌÁö Á¤º¸ 96 Pages
°¡°Ý
US $ 6,000 £Ü 7,149,000 Web Access (Regional License)
US $ 6,500 £Ü 7,744,700 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

This strategic analysis identifies the current trends in scientific business intelligence (Sci-BI) in pharmaceutical and biotechnology markets. Major global healthcare trends are analyzed and the impacts on Sci-BI are delineated. A close look at drivers and restraints in the Sci-BI space revealed interesting growth stimulators while also identifying critical road blocks in the growth of the Sci-BI market. A step by step analysis of the R&D cost distribution in pharma/biotech was carried out together with a competitive landscape analysis of the different players in this niche market segment.

Table of Contents

1. INTRODUCTION

Title Page

  • Title Page

Disclaimer

  • Disclaimer

Certification

  • Certification

Table of Contents

  • Table of Contents

Notes on Methodology

  • Notes on Methodology

2. MARKET INTRODUCTION AND SEGMENTATION

Introduction

  • Introduction

Segmentation

  • Segmentation

3. MAJOR GLOBAL TRENDS IN HEALTHCARE

Major Global Healthcare Trends

  • Major Global Healthcare Trends

4. CURRENT INDUSTRY TRENDS IN SCI-BI

Current Industry Trends in Sci-BI

  • Current Industry Trends in Sci-BI

5. SCI-BI DRIVERS AND RESTRAINTS

Overall Market Drivers and Restraints

  • Overall Market Drivers and Restraints

Sci-BI Drivers

  • Drivers for Sci-BI in Pharma/Biotech Ranked in Order of Impact 2008-2015

Sci-BI Restraints

  • Restraints for Sci-BI in Pharma/Biotech Ranked in Order of Impact 2008-2015

6. SCI-BI OPPORTUNITY ANALYSIS

Opportunity Analysis - Major Areas of Convergence

  • Opportunity Analysis - Major Areas of Convergence

Opportunity Analysis: Growth Drivers for Sci-BI & Workflow Management

  • Opportunity Analysis: Growth Drivers for Sci-BI & Workflow Management

7. PHARMA/BIOTECH R&D & SCI-BI

The ROI Challenge for Pharma

  • The ROI Challenge for Pharma

Pharmaceutical R&D Expenditure

  • Pharmaceutical R&D Expenditure

End to End Sci-BI Services

  • End to End Sci-BI Services

8. SCI-BI MARKETS COMPETITIVE LANDSCAPE

Sci-BI Markets: Competitive Landscape

  • Competitive Analysis by Company

9. CHALLENGES AND CONCLUSIONS

Challenges & Conclusions

  • Challenges & Conclusions

10. ABOUT FROST & SULLIVAN

About Frost & Sullivan

  • About Frost & Sullivan
Back to Top